The Impact of Upper Gastrointestinal Symptoms on Nonadherence to, and Discontinuation of, Low-Dose Acetylsalicylic Acid in Patients with Cardiovascular Risk

Author： Pratt Stephen  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.10, Iss.5, 2010-10, pp. : 281-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-compliance and discontinuation increases the risk of cardiovascular events in patients receiving low-dose aspirin

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 11, 2010-11 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Anti-thrombin action of low-dose acetylsalicylic acid

By Di Micco B.   Colonna G.   Di Micco P.   Di Micco G.   Russo B.M.   Macalello M.A.   Ragone R.  

European Journal of Pharmacology, Vol. 460, Iss. 1, 2003-01 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite

Fixed-dose acetylsalicylic acid/esomeprazole: a guide to its use to prevent cardiovascular events and reduce peptic ulcer risk

By Lyseng-Williamson Katherine A.   Burness Celeste B.   Scott Lesley J.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 6, 2012-06 ,pp. : 10-14

Adis International

Access to resources Recommend Favorite

Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin

By  

Current Pharmaceutical Design, Vol. 21, Iss. 35, 2015-10 ,pp. : 5049-5055

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of Upper Gastrointestinal Ulcer and Complications in Low-Dose Aspirin Users

By  

Current Pharmaceutical Design, Vol. 21, Iss. 35, 2015-10 ,pp. : 5082-5088

Bentham Science Publishers

Access to resources Recommend Favorite